CD8型
代谢物
生物
细胞毒性T细胞
淋巴细胞性脉络膜脑膜炎
慢性感染
代谢组学
病毒
免疫学
病毒载量
免疫系统
离体
病毒学
新陈代谢
炎症
体内
效应器
T细胞
发病机制
脂质代谢
CD3型
转录组
代谢组
免疫
病毒感染
氧化磷酸化
作者
Katelynn R. Kazane,Lara Labarta-Bajo,Dina R. Zangwill,Kalle Liimatta,Fernando Vargas,Kelly C. Weldon,PC Dorrestein,Elina I. Zúñiga
标识
DOI:10.1073/pnas.2419820122
摘要
Chronic infections induce CD8 T cell exhaustion, marked by impaired effector function. While intrinsic drivers are well studied, the role of the surrounding metabolic environment in shaping exhausted CD8 T cells (Tex) is less understood. Using untargeted metabolomics and the murine lymphocytic choriomeningitis virus infection model, we investigated systemic metabolite changes following acute vs. chronic viral infections. We identified distinct short-term and persistent metabolite shifts, with the most significant differences occurring transiently during the early phase of the sustained infection. This included nutrient changes that were partially associated with CD8 T cell-induced anorexia and lipolysis. One remarkable observation was the elevation of medium- and long-chain fatty acids (FA) and acylcarnitines during the first week after chronic infection. Consistently, virus-specific CD8 T cells from chronic infection exhibited increased lipid accumulation and uptake compared to their counterparts from acute infection, particularly the stem-like Tex (TexSTEM), which generates TexINT that directly limit viral replication. Notably, only TexSTEM increased oxidative metabolism upon ex vivo FA exposure, while short-term administration of FA during late chronic infection exclusively increased TexSTEM and their mitochondrial potential. The last-mentioned treatment also led to reduced TexINT and enhanced PD-1 across all Tex subsets, which coincided with compromised viral control. Our study offers a valuable resource for investigating the regulatory role of specific metabolites during acute and chronic viral infections and highlights the potential of FA to fine-tune Tex subsets during protracted infections.
科研通智能强力驱动
Strongly Powered by AbleSci AI